EUVIMEDEUVIMED entdecken
Crossref

Business Round-Up: Q1–Q2 2026 Activity in the Nephrology Industry

Melissa West

Kidney News · 07.08.2026 · 18 (8) · 26-27

DOI: 10.62716/kn.004202026 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Kidney News, erschienen am 07.08.2026. Verfasst von Melissa West. Die Arbeit nennt 6 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Twice a year, Kidney News publishes a high-level review of US Food and Drug Administration (FDA) regulatory approvals, scientific results from industry, investments, and mergers and acquisitions to ensure the ASN membership is well-informed. More than 500 data points, collected from January 1 to June 30, 2026, generated the following analyses and summaries.

Zitieren

APA

West, M. (2026). Business Round-Up: Q1–Q2 2026 Activity in the Nephrology Industry. Kidney News, 18(8), 26-27. https://doi.org/10.62716/kn.004202026

Vancouver

West M. Business Round-Up: Q1–Q2 2026 Activity in the Nephrology Industry. Kidney News. 2026;18(8):26-27. doi:10.62716/kn.004202026

BibTeX
@article{West2026,
  author = {West, Melissa},
  title = {Business Round-Up: Q1–Q2 2026 Activity in the Nephrology Industry},
  journal = {Kidney News},
  year = {2026},
  volume = {18},
  number = {8},
  pages = {26--27},
  doi = {10.62716/kn.004202026}
}
Kostenlos starten →